LON:EKF EKF Diagnostics (EKF) Share Price, News & Analysis GBX 24.78 +0.18 (+0.75%) As of 09:56 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and Trends About EKF Diagnostics Stock (LON:EKF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get EKF Diagnostics alerts:Sign Up Key Stats Today's Range 24.78▼ 25.4050-Day Range 24.40▼ 26.7052-Week Range 22▼ 31.70Volume45 shsAverage Volume369,805 shsMarket Capitalization£106.11 millionP/E Ratio52.73Dividend Yield4.65%Price TargetGBX 35Consensus RatingBuy Company Overview EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide. Read More EKF Diagnostics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks40th Percentile Overall ScoreEKF MarketRank™: EKF Diagnostics scored higher than 40% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingEKF Diagnostics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and no sell ratings.Upside PotentialEKF Diagnostics has a consensus price target of GBX 35, representing about 37.8% upside from its current price of GBX 25.40.Amount of Analyst CoverageEKF Diagnostics has received no research coverage in the past 90 days.Read more about EKF Diagnostics' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of EKF Diagnostics is 54.04, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.77.Price to Earnings Ratio vs. SectorThe P/E ratio of EKF Diagnostics is 54.04, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.69.Price to Book Value per Share RatioEKF Diagnostics has a P/B Ratio of 1.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for EKF. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipEKF Diagnostics is a leading dividend payer. It pays a dividend yield of 4.65%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthEKF Diagnostics does not have a long track record of dividend growth.Read more about EKF Diagnostics' dividend. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for EKF Diagnostics this week, compared to 0 articles on an average week. Company Ownership1.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, EKF Diagnostics insiders have not sold or bought any company stock.Percentage Held by Insiders40.20% of the stock of EKF Diagnostics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions22.24% of the stock of EKF Diagnostics is held by institutions.Read more about EKF Diagnostics' insider trading history. Receive EKF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EKF Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EKF Stock News HeadlinesEKF Diagnostics : Connect with EKF Diagnostics at EAHS Africa 2026September 24, 2026 | marketscreener.comMEKF Diagnostics (LON:EKF) Stock Crosses Above Two Hundred Day Moving Average - What's Next?September 24, 2026 | americanbankingnews.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.October 1 at 1:00 AM | Stansberry Research (Ad)EKF Diagnostics Holdings Plc H1 Income ClimbsSeptember 15, 2026 | rttnews.comEKF Diagnostics H1 Revenue Holds at £25 Million as Adjusted EBITDA Rises 2.4%September 15, 2026 | uk.finance.yahoo.comEKF Profit Narrows To £3 Mln In H1; Plans Re-brand Of Contract Manufacturing BusinessSeptember 15, 2026 | rttnews.comEKF Diagnostics (EKF) Stock Forecast & Price TargetAugust 20, 2026 | investing.comDiagnostics firm EKF upbeat on full year trading while cash held in Russia risesJuly 30, 2026 | msn.comSee More Headlines EKF Stock Analysis - Frequently Asked Questions How have EKF shares performed this year? EKF Diagnostics' stock was trading at GBX 26.10 on January 1st, 2026. Since then, EKF stock has decreased by 2.7% and is now trading at GBX 25.40. How were EKF Diagnostics' earnings last quarter? EKF Diagnostics Holdings plc (LON:EKF) announced its quarterly earnings results on Tuesday, September, 15th. The company reported $0.54 earnings per share (EPS) for the quarter. EKF Diagnostics had a net margin of 4.86% and a trailing twelve-month return on equity of 3.58%. How do I buy shares of EKF Diagnostics? Shares of EKF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of EKF Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that EKF Diagnostics investors own include ERBA Diagnostics (ERBA), boohoo group (BOO), Lloyds Banking Group (LLOY), 888 (888), Abcam (ABC), ASOS (ASC) and Babcock International Group (BAB). Company Calendar Last Earnings9/15/2026Today10/01/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolLON:EKF CIKN/A Webwww.ekfdiagnostics.com Phone+44-29-20710570FaxN/AEmployees356Year FoundedN/APrice Target and Rating Average Price Target for EKF DiagnosticsGBX 35 High Price TargetGBX 35 Low Price TargetGBX 35 Potential Upside/Downside+41.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)GBX 0.47 Trailing P/E Ratio52.73 Forward P/E Ratio10.78 P/E GrowthN/ANet Income£4.68 million Net Margins4.86% Pretax MarginN/A Return on Equity3.58% Return on Assets5.27% Debt Debt-to-Equity Ratio2.09 Current Ratio4.72 Quick Ratio1.77 Sales & Book Value Annual Sales£51.35 million Price / Sales2.07 Cash FlowGBX 2.33 per share Price / Cash Flow10.64 Book ValueGBX 15.41 per share Price / Book1.61Miscellaneous Outstanding Shares428,153,000Free FloatN/AMarket Cap£106.11 million OptionableNot Optionable Beta0.50 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (LON:EKF) was last updated on 10/1/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EKF Diagnostics Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share EKF Diagnostics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
